lixisenatide AVE0010: Clinical Trials

2 trials of lixisenatide AVE0010, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow lixisenatide AVE0010: new trials by email Literature Review of lixisenatide AVE0010 trials Research Report on lixisenatide AVE0010

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
lixisenatide AVE0010 - Type 2 Diabetes Mellitus
Phase 3CompletedSanofi3612013-11-012015-04-09
Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
lixisenatide AVE0010, biguanide, TZD - Type 2 Diabetes Mellitus
Phase 3CompletedSanofi2942013-09-012015-08-04

Conditions studied

Diabetes Mellitus, Type 2 (2)

Sponsors

Sanofi (2)

Countries

Japan (2)